- Home
- HBCP vs ORGO Comparison
HBCP vs ORGO Comparison
Compare HBCP & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBCP
- ORGO
- Stock Information
- Founded
- HBCP 1908
- ORGO 1985
- Country
- HBCP United States
- ORGO United States
- Employees
- HBCP N/A
- ORGO N/A
- Industry
- HBCP Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- HBCP Finance
- ORGO Health Care
- Exchange
- HBCP Nasdaq
- ORGO Nasdaq
- Market Cap
- HBCP 398.8M
- ORGO 418.7M
- IPO Year
- HBCP 2008
- ORGO N/A
- Fundamental
- Price
- HBCP $46.51
- ORGO $3.34
- Analyst Decision
- HBCP Buy
- ORGO Strong Buy
- Analyst Count
- HBCP 2
- ORGO 2
- Target Price
- HBCP $46.50
- ORGO $5.00
- AVG Volume (30 Days)
- HBCP 25.4K
- ORGO 607.1K
- Earning Date
- HBCP 01-27-2025
- ORGO 02-27-2025
- Dividend Yield
- HBCP 2.24%
- ORGO N/A
- EPS Growth
- HBCP N/A
- ORGO N/A
- EPS
- HBCP 4.51
- ORGO N/A
- Revenue
- HBCP $130,219,000.00
- ORGO $455,038,000.00
- Revenue This Year
- HBCP N/A
- ORGO $9.65
- Revenue Next Year
- HBCP $4.77
- ORGO $1.57
- P/E Ratio
- HBCP $10.31
- ORGO N/A
- Revenue Growth
- HBCP N/A
- ORGO 1.34
- 52 Week Low
- HBCP $33.30
- ORGO $2.17
- 52 Week High
- HBCP $52.39
- ORGO $4.57
- Technical
- Relative Strength Index (RSI)
- HBCP 51.75
- ORGO 53.23
- Support Level
- HBCP $44.75
- ORGO $2.88
- Resistance Level
- HBCP $46.33
- ORGO $3.24
- Average True Range (ATR)
- HBCP 1.37
- ORGO 0.16
- MACD
- HBCP 0.19
- ORGO 0.04
- Stochastic Oscillator
- HBCP 89.82
- ORGO 90.29
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans. Its primary expenses are interest expense on deposits and borrowings and general operating expenses.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.